Nifty
Sensex
:
:
11873.05
40431.60
110.60 (0.94%)
448.62 (1.12%)

Pharmaceuticals & Drugs

Rating :
86/99  (View)

BSE: 541096 | NSE: Not Listed

388.15
5.75 (1.50%)
19-Oct-2020 | 3:34PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  399.85
  •  401.50
  •  388.00
  •  382.40
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  3852
  •  14.95
  •  514.00
  •  131.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 219.10
  • 8.41
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 211.81
  • N/A
  • 1.76

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 74.42%
  • 6.64%
  • 16.88%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 2.06%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.94
  • 13.09
  • 25.36

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.16
  • 22.50
  • 34.89

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.84
  • 24.85
  • 45.56

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
55
50
11%
55
41
33%
74
90
-17%
50
51
-2%
Expenses
47
44
6%
48
38
27%
63
82
-23%
45
39
15%
EBITDA
8
6
44%
7
3
106%
11
8
46%
4
11
-61%
EBIDTM
15%
11%
13%
8%
15%
9%
9%
22%
Other Income
2
3
-24%
2
5
-55%
3
5
-45%
4
1
152%
Interest
0
0
-56%
0
0
92%
0
0
-10%
0
0
-27%
Depreciation
1
2
-17%
1
2
-17%
1
2
-5%
1
1
0%
PBT
9
7
29%
7
6
19%
12
11
14%
6
11
-43%
Tax
3
2
8%
0
1
-84%
4
4
-3%
2
7
-69%
PAT
7
5
40%
7
5
36%
8
6
24%
4
4
-2%
PATM
12%
10%
13%
13%
11%
7%
8%
8%
EPS
11.65
8.33
40%
12.51
9.18
36%
14.19
11.40
24%
7.35
7.51
-2%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
233
220
137
111
124
Net Sales Growth
1%
61%
23%
-10%
 
Cost Of Goods Sold
153
140
88
79
83
Gross Profit
81
79
48
32
41
GP Margin
34%
36%
35%
29%
33%
Total Expenditure
203
191
124
105
114
Power & Fuel Cost
-
3
3
2
2
% Of Sales
-
1%
2%
2%
2%
Employee Cost
-
15
13
11
9
% Of Sales
-
7%
9%
10%
7%
Manufacturing Exp.
-
9
5
4
4
% Of Sales
-
4%
4%
4%
3%
General & Admin Exp.
-
3
2
1
5
% Of Sales
-
2%
1%
1%
4%
Selling & Distn. Exp.
-
14
10
4
10
% Of Sales
-
6%
7%
4%
8%
Miscellaneous Exp.
-
6
4
3
1
% Of Sales
-
3%
3%
2%
1%
EBITDA
31
29
12
6
10
EBITDA Margin
13%
13%
9%
6%
8%
Other Income
11
13
7
8
5
Interest
1
1
1
1
1
Depreciation
6
6
6
6
4
PBT
35
35
13
7
9
Tax
9
13
4
1
3
Tax Rate
25%
39%
29%
8%
31%
PAT
26
21
9
7
6
PAT before Minority Interest
26
21
9
7
6
Minority Interest
0
0
0
0
0
PAT Margin
11%
10%
7%
6%
5%
PAT Growth
25%
133%
32%
7%
 
EPS
45.70
37.28
16.00
12.09
11.32

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
94
73
64
57
Share Capital
6
6
6
6
Total Reserves
88
67
58
51
Non-Current Liabilities
4
0
3
7
Secured Loans
1
2
4
7
Unsecured Loans
0
0
0
0
Long Term Provisions
0
0
0
0
Current Liabilities
61
57
43
56
Trade Payables
32
27
36
39
Other Current Liabilities
26
22
6
0
Short Term Borrowings
2
5
0
13
Short Term Provisions
1
3
0
4
Total Liabilities
159
130
110
120
Net Block
34
34
31
35
Gross Block
50
44
36
62
Accumulated Depreciation
16
10
5
28
Non Current Assets
41
39
46
49
Capital Work in Progress
1
0
0
0
Non Current Investment
1
0
1
0
Long Term Loans & Adv.
2
3
10
9
Other Non Current Assets
3
3
4
4
Current Assets
118
91
64
72
Current Investments
1
1
0
0
Inventories
23
14
15
14
Sundry Debtors
64
59
44
44
Cash & Bank
12
4
2
13
Other Current Assets
18
1
3
1
Short Term Loans & Adv.
18
13
0
0
Net Current Assets
58
34
21
15
Total Assets
159
130
110
120

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
20
6
-2
0
PBT
35
13
7
0
Adjustment
7
6
6
0
Changes in Working Capital
-10
-10
-14
0
Cash after chg. in Working capital
31
9
-1
0
Interest Paid
0
0
0
0
Tax Paid
-10
-3
-2
0
Other Direct Exp. Paid
0
0
0
0
Extra & Other Items
0
0
0
0
Cash From Investing Activity
-9
-8
-2
0
Net Fixed Assets
-7
-8
26
Net Investments
-2
0
0
Others
0
0
-28
Cash from Financing Activity
-4
4
-8
0
Net Cash Inflow / Outflow
7
2
-11
0
Opening Cash & Equivalents
4
2
13
0
Closing Cash & Equivalent
11
4
2
0

Financial Ratios

Standalone /

Consolidated
Description
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
164
127
111
99
ROA
15%
8%
6%
5%
ROE
25%
13%
11%
11%
ROCE
39%
18%
11%
14%
Fixed Asset Turnover
4.66
3.46
2.41
2.10
Receivable days
102
135
135
123
Inventory Days
31
39
45
39
Payable days
57
92
127
125
Cash Conversion Cycle
76
81
53
37
Total Debt/Equity
0.05
0.12
0.10
0.34
Interest Cover
41
15
9
7

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.